Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter's chief financial ...

This was the stock's second consecutive day of losses.

Baxter International Inc. BAX is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is ...

Crain’s health care reporter Katherine Davis discusses recent leadership moves at Baxter International and Howard Brown ...

DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market ...

Baxter International Inc. closed 29.99% short of its 52-week high of $44.01, which the company reached on March 8th.

Brent Shafer, who was appointed as Baxter’s Chair and Interim CEO in February 2025, has served as the Chairman and CEO of ...

Baxter International Inc. (BAX), a healthcare company, Monday announced the appointment of Lead Independent Director Brent Shafer as ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with ...

Baxter International seems pretty uncompelling as an investment opportunity, and investors should look elsewhere. Even so, within each business segment, we see there are different important ...